<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
 <channel>
  <atom:link href="https://www.openpr.com/rss/06-health-medicine.xml" rel="self" type="application/rss+xml" />
  <title>openPR.com - New Public Relations: Health &amp; Medicine</title>
  <link>https://www.openpr.com/news/categories2-6-Health-Medicine.html</link>
  <pubDate>Fri, 17 Apr 2026 01:15:56 +0200</pubDate>
  <image>
   <url>https://www.openpr.com/images/logo.jpg</url>
   <title>openPR.com - New Public Relations: Health &amp; Medicine</title>
   <link>https://www.openpr.com/news/categories2-6-Health-Medicine.html</link>
  </image>
 <description>openPR.com - Publish Press Releases Free of Charge</description>
 <language>en</language>
<item>
 <title>Elite Hearing of Colorado Springs Highlights Professional Ear Wax Removal Services to Improve Hearing Health</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/417931618_k.jpg" alt="Elite Hearing of Colorado Springs Highlights Professional Ear Wax Removal Services to Improve Hearing Health" align="left" hspace="5" /><br/>Image: https://www.globalnewslines.com/uploads/2026/04/1776371857.jpg

Colorado Springs, CO - Elite Hearing of Colorado Springs is raising awareness of the importance of professional ear wax removal as part of its comprehensive audiology services, helping local residents protect their hearing and overall ear health. With an<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475633/elite-hearing-of-colorado-springs-highlights-professional-ear</link>
 <author>Getnews</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475633/elite-hearing-of-colorado-springs-highlights-professional-ear</guid>
 <pubDate>Fri, 17 Apr 2026 01:14:04 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/417931618_k.jpg" length="1862" type="image/jpeg" />
</item>
<item>
 <title>Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Desire</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/417865523_k.jpg" alt="Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Desire" align="left" hspace="5" /><br/>A new patient resource from a leading cosmetic dentist in Stamford, CT addresses the fears, misconceptions, and outdated beliefs that prevent adults from exploring modern cosmetic dentistry options.
STAMFORD, CT - April 16, 2026 - Dental Care of Stamford [https://dentalcarestamford.com/], a<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475604/dental-care-of-stamford-challenges-the-myths-holding-stamford</link>
 <author>Getnews</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475604/dental-care-of-stamford-challenges-the-myths-holding-stamford</guid>
 <pubDate>Fri, 17 Apr 2026 00:52:06 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/417865523_k.jpg" length="2488" type="image/jpeg" />
</item>
<item>
 <title>CEO Weekly Features ReliefNow Registered Hamlin's Non-Surgical Pain Solutions for Central Florida</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/417125555_k.jpg" alt="CEO Weekly Features ReliefNow Registered Hamlin's Non-Surgical Pain Solutions for Central Florida" align="left" hspace="5" /><br/>Dr. Jeffrey N. Shebovsky's Greater Orlando Practice Featured for Its Proprietary Gentle and Painless Disc and Nerve Care
Image: https://authoritypresswire.com/wp-content/uploads/2026/04/CEO-WEEKLY_IMAGE.jpg

ReliefNow Registered DiscJointNerve Hamlin, located at 5736 Hamlin Groves Trail, Suite 154, Winter Garden, Florida, has been featured in CEO Weekly for<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475601/ceo-weekly-features-reliefnow-registered-hamlin-s</link>
 <author>Getnews</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475601/ceo-weekly-features-reliefnow-registered-hamlin-s</guid>
 <pubDate>Fri, 17 Apr 2026 00:50:05 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/417125555_k.jpg" length="1539" type="image/jpeg" />
</item>
<item>
 <title>ReliefNow Registered Hamlin Spotlighted in Kivo Daily for Non-Surgical Disc and Nerve Care</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/417745911_k.jpg" alt="ReliefNow Registered Hamlin Spotlighted in Kivo Daily for Non-Surgical Disc and Nerve Care" align="left" hspace="5" /><br/>Dr. Jeffrey N. Shebovsky's Winter Garden Practice Recognized for Its Proprietary Gentle, Painless Approach to Disc, Joint, and Nerve Conditions
Image: https://authoritypresswire.com/wp-content/uploads/2026/04/04_KIVO-DAILY_IMAGE_RESIZED.jpg

ReliefNow Registered DiscJointNerve Hamlin, located at 5736 Hamlin Groves Trail, Suite 154, Winter Garden, Florida, has been featured in Kivo<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475600/reliefnow-registered-hamlin-spotlighted-in-kivo-daily</link>
 <author>Getnews</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475600/reliefnow-registered-hamlin-spotlighted-in-kivo-daily</guid>
 <pubDate>Fri, 17 Apr 2026 00:48:04 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/417745911_k.jpg" length="2385" type="image/jpeg" />
</item>
<item>
 <title>ReliefNow Registered Hamlin Featured in US Reporter for Clinically Supported Non-Surgical Pain Relief</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/417212746_k.jpg" alt="ReliefNow Registered Hamlin Featured in US Reporter for Clinically Supported Non-Surgical Pain Relief" align="left" hspace="5" /><br/>Dr. Jeffrey N. Shebovsky's Winter Garden practice highlighted for helping patients skip the scalpel and ditch the drugs through disc decompression and Class IV laser therapy
Image: https://authoritypresswire.com/wp-content/uploads/2026/04/02_US-REPORTER-IMAGE-_RESIZE.jpg

ReliefNow Registered DiscJointNerve Hamlin has been featured in US Reporter for its non-surgical, drug-free<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475597/reliefnow-registered-hamlin-featured-in-us-reporter</link>
 <author>Getnews</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475597/reliefnow-registered-hamlin-featured-in-us-reporter</guid>
 <pubDate>Fri, 17 Apr 2026 00:46:04 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/417212746_k.jpg" length="3353" type="image/jpeg" />
</item>
<item>
 <title>Osteoarthritis Pipeline 2026 FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416742032_k.jpg" alt="Osteoarthritis Pipeline 2026 FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight" align="left" hspace="5" /><br/>(Las Vegas, Nevada, United States)  As per DelveInsight's assessment, globally, Osteoarthritis pipeline constitutes 100+ key companies continuously working towards developing 110+ Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475416/osteoarthritis-pipeline-2026-fda-updates-therapy</link>
 <author>DelveInsight Business Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475416/osteoarthritis-pipeline-2026-fda-updates-therapy</guid>
 <pubDate>Thu, 16 Apr 2026 20:51:39 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416742032_k.jpg" length="1177" type="image/jpeg" />
</item>
<item>
 <title>Fabry Disease Market: Rapid Increment Driven by Innovation by 2034 - DelveInsight</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416899577_k.jpg" alt="Fabry Disease Market: Rapid Increment Driven by Innovation by 2034 - DelveInsight" align="left" hspace="5" /><br/>DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fabry Disease, historical and forecasted epidemiology as well as the Fabry Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475414/fabry-disease-market-rapid-increment-driven-by-innovation</link>
 <author>DelveInsight Business Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475414/fabry-disease-market-rapid-increment-driven-by-innovation</guid>
 <pubDate>Thu, 16 Apr 2026 20:49:28 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416899577_k.jpg" length="1177" type="image/jpeg" />
</item>
<item>
 <title>Rett Syndrome Market: Accelerating Growth and Pipeline Impact by 2034 - DelveInsight</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416954871_k.jpg" alt="Rett Syndrome Market: Accelerating Growth and Pipeline Impact by 2034 - DelveInsight" align="left" hspace="5" /><br/>DelveInsight's "Rett Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Rett Syndrome, historical and forecasted epidemiology as well as the Rett Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475410/rett-syndrome-market-accelerating-growth-and-pipeline-impact</link>
 <author>DelveInsight Business Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475410/rett-syndrome-market-accelerating-growth-and-pipeline-impact</guid>
 <pubDate>Thu, 16 Apr 2026 20:48:28 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416954871_k.jpg" length="1177" type="image/jpeg" />
</item>
<item>
 <title>General Anesthesia Drugs Market size to Reach USD 6.74 Billion by 2031, Driven by Rising Surgical Demand</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/416927102_k.jpg" alt="General Anesthesia Drugs Market size to Reach USD 6.74 Billion by 2031, Driven by Rising Surgical Demand" align="left" hspace="5" /><br/>Mordor Intelligence has published a new report on the general anesthesia drugs market, offering a comprehensive analysis of trends, growth drivers, and future projections.
General Anesthesia Drugs Market Overview

According to Mordor Intelligence, the general anesthesia drugs market size [https://www.mordorintelligence.com/industry-reports/global-general-anesthesia-drugs-market?utm_source=abnewswire] was valued<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475373/general-anesthesia-drugs-market-size-to-reach-usd-6-74-billion</link>
 <author>ABNewswire</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475373/general-anesthesia-drugs-market-size-to-reach-usd-6-74-billion</guid>
 <pubDate>Thu, 16 Apr 2026 20:16:04 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/416927102_k.jpg" length="1739" type="image/jpeg" />
</item>
<item>
 <title>Ophthalmology PACS (Picture Archiving and Communication System) Market size to Reach USD 270.95 Million by 2031 Driven by Digital Imaging Adoption</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/416333498_k.jpg" alt="Ophthalmology PACS (Picture Archiving and Communication System) Market size to Reach USD 270.95 Million by 2031 Driven by Digital Imaging Adoption" align="left" hspace="5" /><br/>Mordor Intelligence has published a new report on the ophthalmology PACS (picture archiving and communication system) market, offering a comprehensive analysis of trends, growth drivers, and future projections.

Introduction

According to Mordor Intelligence, the ophthalmology PACS (picture archiving and communication system) market<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475371/ophthalmology-pacs-picture-archiving-and-communication</link>
 <author>ABNewswire</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475371/ophthalmology-pacs-picture-archiving-and-communication</guid>
 <pubDate>Thu, 16 Apr 2026 20:14:05 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/416333498_k.jpg" length="1641" type="image/jpeg" />
</item>
<item>
 <title>Ovarian Cancer Pipeline Expands with 180+ Companies and 200+ Emerging Therapies, Finds DelveInsight | Genentech, Genmab, AstraZeneca, GSK, Merck, Novartis, Allarity Therapeutics</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416258806_k.jpg" alt="Ovarian Cancer Pipeline Expands with 180+ Companies and 200+ Emerging Therapies, Finds DelveInsight | Genentech, Genmab, AstraZeneca, GSK, Merck, Novartis, Allarity Therapeutics" align="left" hspace="5" /><br/>DelveInsight's "Ovarian Cancer - Pipeline Insight, 2026" report provides comprehensive insights about 180+ companies and more than 200 pipeline drugs in the Ovarian Cancer pipeline landscape. It covers the Ovarian Cancer pipeline drug profiles, including clinical and nonclinical stage products,<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475355/ovarian-cancer-pipeline-expands-with-180-companies-and-200</link>
 <author>DelveInsight</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475355/ovarian-cancer-pipeline-expands-with-180-companies-and-200</guid>
 <pubDate>Thu, 16 Apr 2026 19:54:12 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416258806_k.jpg" length="1451" type="image/jpeg" />
</item>
<item>
 <title>Pain Management Devices Market Poised to Reach USD 32.19 Billion by 2034 with a 10.68% CAGR: DelveInsight | Abbott, Medtronic, and Boston Scientific</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416806507_k.jpg" alt="Pain Management Devices Market Poised to Reach USD 32.19 Billion by 2034 with a 10.68% CAGR: DelveInsight | Abbott, Medtronic, and Boston Scientific" align="left" hspace="5" /><br/>The global pain management devices market is witnessing significant transformation, propelled by the rising prevalence of chronic pain conditions, a strategic shift away from opioid-based therapies, and rapid technological integration such as AI-driven neuromodulation and wearable solutions.

Key Takeaways

• February 2026:<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475351/pain-management-devices-market-poised-to-reach-usd-32-19-billion</link>
 <author>DelveInsight</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475351/pain-management-devices-market-poised-to-reach-usd-32-19-billion</guid>
 <pubDate>Thu, 16 Apr 2026 19:52:33 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416806507_k.jpg" length="1451" type="image/jpeg" />
</item>
<item>
 <title>Contraceptive Devices Market Projected to Reach USD 32.8 Billion by 2032, Driven by 6.28% CAGR and Rising Global Awareness: DelveInsight | Bayer, Reckitt Benckiser, and Organon</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416401037_k.jpg" alt="Contraceptive Devices Market Projected to Reach USD 32.8 Billion by 2032, Driven by 6.28% CAGR and Rising Global Awareness: DelveInsight | Bayer, Reckitt Benckiser, and Organon" align="left" hspace="5" /><br/>The global contraceptive devices market is poised for robust expansion, fueled by increasing awareness of family planning, demographic shifts such as delayed parenthood, and the continuous innovation in long-acting reversible contraceptives (LARCs) that offer high efficacy and fewer side effects<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475349/contraceptive-devices-market-projected-to-reach-usd-32-8</link>
 <author>DelveInsight</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475349/contraceptive-devices-market-projected-to-reach-usd-32-8</guid>
 <pubDate>Thu, 16 Apr 2026 19:51:18 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416401037_k.jpg" length="1451" type="image/jpeg" />
</item>
<item>
 <title>Patient Derived Xenograft/PDX Models Market Size Expanding at 10.9% CAGR | By Key Players: Charles River Laboratories, The Jackson Laboratory, Crown Bioscience, Taconic Biosciences, Horizon Discovery, Champions Oncology</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416482886_k.jpg" alt="Patient Derived Xenograft/PDX Models Market Size Expanding at 10.9% CAGR | By Key Players: Charles River Laboratories, The Jackson Laboratory, Crown Bioscience, Taconic Biosciences, Horizon Discovery, Champions Oncology" align="left" hspace="5" /><br/>Patient Derived Xenograft/PDX Models Market Size Expanding at 10.9% CAGR | By Key Players: Charles River Laboratories, The Jackson Laboratory, Crown Bioscience, Taconic Biosciences, Horizon Discovery, Champions Oncology
The US-Iran war has indirectly influenced the Patient Derived Xenograft/PDX Models Market by<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475298/patient-derived-xenograft-pdx-models-market-size-expanding</link>
 <author>Verified Market Reports</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475298/patient-derived-xenograft-pdx-models-market-size-expanding</guid>
 <pubDate>Thu, 16 Apr 2026 19:12:46 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416482886_k.jpg" length="1828" type="image/jpeg" />
</item>
<item>
 <title>Healthcare Risk Management Market is Booming Worldwide | Major Giants IBM, Oracle, SAP, Optum, Cerner</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416217710_k.jpg" alt="Healthcare Risk Management Market is Booming Worldwide | Major Giants IBM, Oracle, SAP, Optum, Cerner" align="left" hspace="5" /><br/>The Global Healthcare Risk Management Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475296/healthcare-risk-management-market-is-booming-worldwide-major</link>
 <author>HTF Market Intelligence Consulting Private Limited</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475296/healthcare-risk-management-market-is-booming-worldwide-major</guid>
 <pubDate>Thu, 16 Apr 2026 19:12:02 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416217710_k.jpg" length="2202" type="image/jpeg" />
</item>
<item>
 <title>Blood Plasma Market Size Accelerated at 8.1% CAGR | By Key Players: CSL Limited, Grifols, Takeda Pharmaceutical, Octapharma, Kedrion Biopharma, Biotest AG</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416685503_k.jpg" alt="Blood Plasma Market Size Accelerated at 8.1% CAGR | By Key Players: CSL Limited, Grifols, Takeda Pharmaceutical, Octapharma, Kedrion Biopharma, Biotest AG" align="left" hspace="5" /><br/>Blood Plasma Market Size Accelerated at 8.1% CAGR | By Key Players: CSL Limited, Grifols, Takeda Pharmaceutical, Octapharma, Kedrion Biopharma, Biotest AG
The US-Iran war has introduced indirect but material implications for the Blood Plasma Market by disrupting global logistics, increasing<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475264/blood-plasma-market-size-accelerated-at-8-1-cagr-by-key</link>
 <author>Verified Market Reports</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475264/blood-plasma-market-size-accelerated-at-8-1-cagr-by-key</guid>
 <pubDate>Thu, 16 Apr 2026 18:54:55 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416685503_k.jpg" length="1828" type="image/jpeg" />
</item>
<item>
 <title>Circular Dichroism Spectrometers Market Size to Reach USD 58 Million by 2032</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416355068_k.jpg" alt="Circular Dichroism Spectrometers Market Size to Reach USD 58 Million by 2032" align="left" hspace="5" /><br/>Introduction

The Circular Dichroism Spectrometers Market is witnessing steady expansion as advanced analytical techniques become increasingly central to modern life sciences and pharmaceutical research. Circular dichroism (CD) spectroscopy, a powerful method for analyzing the structural properties of biomolecules, has gained significant<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475243/circular-dichroism-spectrometers-market-size-to-reach-usd-58</link>
 <author>Credence Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475243/circular-dichroism-spectrometers-market-size-to-reach-usd-58</guid>
 <pubDate>Thu, 16 Apr 2026 18:39:34 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416355068_k.jpg" length="2012" type="image/jpeg" />
</item>
<item>
 <title>Biotechnology Market: Size, Trends, Growth Drivers, and Future Outlook (2026-2035)</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416614707_k.jpg" alt="Biotechnology Market: Size, Trends, Growth Drivers, and Future Outlook (2026-2035)" align="left" hspace="5" /><br/>The biotechnology market represents one of the most transformative sectors in modern science and healthcare. Biotechnology involves the use of living organisms, cells, and biological systems to develop products and technologies that improve human health, agriculture, and environmental sustainability. From<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475228/biotechnology-market-size-trends-growth-drivers-and-future</link>
 <author>Cervicorn Consulting</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475228/biotechnology-market-size-trends-growth-drivers-and-future</guid>
 <pubDate>Thu, 16 Apr 2026 18:24:36 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416614707_k.jpg" length="2159" type="image/jpeg" />
</item>
<item>
 <title>Active Pharmaceutical Ingredient (API) Market: Growth, Trends, Opportunities, and Forecast (2026-2035)</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416594986_k.jpg" alt="Active Pharmaceutical Ingredient (API) Market: Growth, Trends, Opportunities, and Forecast (2026-2035)" align="left" hspace="5" /><br/>The Active Pharmaceutical Ingredient (API) market forms the backbone of the global pharmaceutical industry. APIs are the biologically active components in drugs that produce the intended therapeutic effects. Whether derived synthetically or biologically, APIs are essential in the formulation of<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475224/active-pharmaceutical-ingredient-api-market-growth</link>
 <author>Cervicorn Consulting</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475224/active-pharmaceutical-ingredient-api-market-growth</guid>
 <pubDate>Thu, 16 Apr 2026 18:20:57 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416594986_k.jpg" length="2213" type="image/jpeg" />
</item>
<item>
 <title>Clinical Trials Market: Growth, Trends, Opportunities, and Future Outlook (2026-2035)</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416818570_k.jpg" alt="Clinical Trials Market: Growth, Trends, Opportunities, and Future Outlook (2026-2035)" align="left" hspace="5" /><br/>The global clinical trials market plays a pivotal role in advancing modern healthcare by enabling the development of new drugs, medical devices, and treatment protocols. Clinical trials are systematic investigations conducted on human participants to evaluate the safety, efficacy, and<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475216/clinical-trials-market-growth-trends-opportunities</link>
 <author>Cervicorn Consulting</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475216/clinical-trials-market-growth-trends-opportunities</guid>
 <pubDate>Thu, 16 Apr 2026 18:14:46 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416818570_k.jpg" length="2182" type="image/jpeg" />
</item>
<item>
 <title>Complex Injectables Market Size to Reach USD 46,572 million by 2032</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416114055_k.jpg" alt="Complex Injectables Market Size to Reach USD 46,572 million by 2032" align="left" hspace="5" /><br/>Introduction
The Complex Injectables Market is experiencing strong growth as pharmaceutical innovation increasingly shifts toward advanced drug delivery systems designed for precision, efficacy, and improved patient outcomes. Complex injectables refer to formulations that require sophisticated manufacturing techniques, sterile handling, and specialized<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475211/complex-injectables-market-size-to-reach-usd-46-572-million</link>
 <author>Credence Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475211/complex-injectables-market-size-to-reach-usd-46-572-million</guid>
 <pubDate>Thu, 16 Apr 2026 18:13:20 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416114055_k.jpg" length="2288" type="image/jpeg" />
</item>
<item>
 <title>Chronic Venous Occlusions Treatment Market Report: Size, Share &amp; Future Outlook</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416710401_k.jpg" alt="Chronic Venous Occlusions Treatment Market Report: Size, Share & Future Outlook" align="left" hspace="5" /><br/>Market Overview

The global Chronic Venous Occlusions Treatment Market is steadily advancing, supported by the increasing burden of venous diseases and continuous innovation in minimally invasive vascular interventions. The market size was estimated at USD 7,419 million in 2025 and is<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475179/chronic-venous-occlusions-treatment-market-report-size-share</link>
 <author>Credence Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475179/chronic-venous-occlusions-treatment-market-report-size-share</guid>
 <pubDate>Thu, 16 Apr 2026 17:53:36 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416710401_k.jpg" length="2109" type="image/jpeg" />
</item>
<item>
 <title>Emerging Trends in Remote Patient Monitoring and Care Market with Strategic Outlook (2026-2030)</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416224730_k.jpg" alt="Emerging Trends in Remote Patient Monitoring and Care Market with Strategic Outlook (2026-2030)" align="left" hspace="5" /><br/>Market Summary
As per Data Bridge Market Research analysis, the Remote Patient Monitoring and Care Market was estimated at USD 14.29 billion in 2025. The market is expected to grow from USD 16.07 billion in 2026 to USD 25.77 billion in<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475143/emerging-trends-in-remote-patient-monitoring-and-care-market</link>
 <author>Data Bridge Market Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475143/emerging-trends-in-remote-patient-monitoring-and-care-market</guid>
 <pubDate>Thu, 16 Apr 2026 17:28:35 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416224730_k.jpg" length="1434" type="image/jpeg" />
</item>
<item>
 <title>Malaria Vaccines Sales Market Analysis By Application, Type, Technology, and Geography - Global Industry Outlook and Forecast 2026-2033</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416445494_k.jpg" alt="Malaria Vaccines Sales Market Analysis By Application, Type, Technology, and Geography - Global Industry Outlook and Forecast 2026-2033" align="left" hspace="5" /><br/>The Malaria Vaccines Sales Market reached a valuation of 6.68 billion in 2025 and is anticipated to expand at a CAGR of 16.09% during the forecast period from 2026 to 2033, ultimately attaining an estimated value of 22.04 billion by<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475140/malaria-vaccines-sales-market-analysis-by-application-type</link>
 <author>Market Research Intellect</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475140/malaria-vaccines-sales-market-analysis-by-application-type</guid>
 <pubDate>Thu, 16 Apr 2026 17:26:31 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416445494_k.jpg" length="1791" type="image/jpeg" />
</item>
<item>
 <title>Medical Cannabis Sales Market Analysis By Application, Type, Technology, and Geography - Global Industry Outlook and Forecast 2026-2033</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416710569_k.jpg" alt="Medical Cannabis Sales Market Analysis By Application, Type, Technology, and Geography - Global Industry Outlook and Forecast 2026-2033" align="left" hspace="5" /><br/>The Medical Cannabis Sales Market reached a valuation of 14.24 billion in 2025 and is anticipated to expand at a CAGR of 7.01% during the forecast period from 2026 to 2033, ultimately attaining an estimated value of 24.49 billion by<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475137/medical-cannabis-sales-market-analysis-by-application-type</link>
 <author>Market Research Intellect</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475137/medical-cannabis-sales-market-analysis-by-application-type</guid>
 <pubDate>Thu, 16 Apr 2026 17:24:38 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416710569_k.jpg" length="1791" type="image/jpeg" />
</item>
<item>
 <title>Best Bunion Treatment (2026) Report Published by Kinross Research</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/416209260_k.jpg" alt="Best Bunion Treatment (2026) Report Published by Kinross Research" align="left" hspace="5" /><br/>Kinross Research Publishes Its Latest Research Report Recognizing the Best Bunion Treatments (2026)
Kinross Research today announced the release of its latest healthcare report, "Best Bunion Treatment (2026): A Research-Style Comparative Review," highlighting the most effective modern approaches for managing and<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475133/best-bunion-treatment-2026-report-published-by-kinross</link>
 <author>ABNewswire</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475133/best-bunion-treatment-2026-report-published-by-kinross</guid>
 <pubDate>Thu, 16 Apr 2026 17:20:08 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/416209260_k.jpg" length="1185" type="image/jpeg" />
</item>
<item>
 <title>Microcarriers Market Growth Forecast 2022-2030: Expected to Hit US$ 4.18 Billion at 12.5% CAGR</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416739632_k.jpg" alt="Microcarriers Market Growth Forecast 2022-2030: Expected to Hit US$ 4.18 Billion at 12.5% CAGR" align="left" hspace="5" /><br/>The microcarriers market has gained significant traction in recent years due to its critical role in cell culture processes, particularly in the production of vaccines, biologics, and regenerative therapies. Microcarriers are small beads that provide a surface for adherent cells<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475102/microcarriers-market-growth-forecast-2022-2030-expected</link>
 <author>The Insight  Partners</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475102/microcarriers-market-growth-forecast-2022-2030-expected</guid>
 <pubDate>Thu, 16 Apr 2026 16:47:53 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416739632_k.jpg" length="1501" type="image/jpeg" />
</item>
<item>
 <title>Contract Research Organization Market Set to Reach US$ 113.79 Billion by 2031, Growing at a CAGR of 8.2% (2024-2031)</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416326385_k.jpg" alt="Contract Research Organization Market Set to Reach US$ 113.79 Billion by 2031, Growing at a CAGR of 8.2% (2024-2031)" align="left" hspace="5" /><br/>The global contract research organization (CRO) market is witnessing robust expansion as pharmaceutical, biotechnology, and medical device companies increasingly outsource research and development (R&D) activities. CROs play a crucial role in accelerating drug development, reducing operational costs, and improving efficiency<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475098/contract-research-organization-market-set-to-reach-us-113-79</link>
 <author>The Insight Partners</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475098/contract-research-organization-market-set-to-reach-us-113-79</guid>
 <pubDate>Thu, 16 Apr 2026 16:37:49 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416326385_k.jpg" length="1513" type="image/jpeg" />
</item>
<item>
 <title>Global Rare Neurological Disease Treatment Market to Cross USD 16 Billion by 2030, Powered by Breakthroughs in Gene Therapy and Precision Medicine</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416677824_k.jpg" alt="Global Rare Neurological Disease Treatment Market to Cross USD 16 Billion by 2030, Powered by Breakthroughs in Gene Therapy and Precision Medicine" align="left" hspace="5" /><br/>The global landscape for treating rare neurological disorders is undergoing a seismic shift. According to the latest market intelligence, the Global Rare Neurological Disease Treatment Market is projected to grow from USD 10.64 billion in 2025 to USD 16.05 billion<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475029/global-rare-neurological-disease-treatment-market-to-cross-usd</link>
 <author>Fact.MR</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475029/global-rare-neurological-disease-treatment-market-to-cross-usd</guid>
 <pubDate>Thu, 16 Apr 2026 15:40:07 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416677824_k.jpg" length="2089" type="image/jpeg" />
</item>
<item>
 <title>Human Microbiome Therapeutics Market Size, Share, Growth Trends, Regional Insights (North America 42%, Europe 27%, Asia Pacific 23%) &amp; Key Players - Seres Therapeutics, Ferring Pharmaceuticals, Vedanta Biosciences, Enterome, MaaT Pharma</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416754583_k.jpg" alt="Human Microbiome Therapeutics Market Size, Share, Growth Trends, Regional Insights (North America 42%, Europe 27%, Asia Pacific 23%) & Key Players - Seres Therapeutics, Ferring Pharmaceuticals, Vedanta Biosciences, Enterome, MaaT Pharma" align="left" hspace="5" /><br/>The global human microbiome therapeutics market reached USD 1.64 billion in 2025 and is expected to reach USD 8.95 billion by 2033, growing at a CAGR of 29.8% from 2026 to 2033. The market is witnessing rapid growth driven by<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475019/human-microbiome-therapeutics-market-size-share-growth</link>
 <author>DataM intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475019/human-microbiome-therapeutics-market-size-share-growth</guid>
 <pubDate>Thu, 16 Apr 2026 15:33:52 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416754583_k.jpg" length="3021" type="image/jpeg" />
</item>
<item>
 <title>What Will Be the Future Growth of the Hospital Information Systems (HIS) Market from USD 95.6 Billion (2022) to USD 178.3 Billion (2031)?</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416951198_k.jpg" alt="What Will Be the Future Growth of the Hospital Information Systems (HIS) Market from USD 95.6 Billion (2022) to USD 178.3 Billion (2031)?" align="left" hspace="5" /><br/>Market Size and Growth 2026

The Global Hospital Information Systems (HIS) Market reached USD 95.6  billion in 2022 and is expected to reach USD 178.3  billion by 2031, growing with a CAGR of 8.3% during the forecast period 2024-2031.

DataM<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4475013/what-will-be-the-future-growth-of-the-hospital-information</link>
 <author>DataM  intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4475013/what-will-be-the-future-growth-of-the-hospital-information</guid>
 <pubDate>Thu, 16 Apr 2026 15:29:57 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416951198_k.jpg" length="2095" type="image/jpeg" />
</item>
<item>
 <title>Protein Engineering Market Set for Rapid Growth to US$ 8,646.10 Million by 2033, Led by North America's 39% Market Share</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416364532_k.jpg" alt="Protein Engineering Market Set for Rapid Growth to US$ 8,646.10 Million by 2033, Led by North America's 39% Market Share" align="left" hspace="5" /><br/>The Global protein engineering market reached US$ 3,300.8 million in 2025 and is expected to reach US$  8,646.10 Million by 2033, growing at a CAGR of 15.6 % during the forecast period of 2026-2033 as global biotechnology and pharmaceutical<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474995/protein-engineering-market-set-for-rapid-growth-to-us-8-646-10</link>
 <author>DataM Intelligence 4Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474995/protein-engineering-market-set-for-rapid-growth-to-us-8-646-10</guid>
 <pubDate>Thu, 16 Apr 2026 15:19:07 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416364532_k.jpg" length="2126" type="image/jpeg" />
</item>
<item>
 <title>Artificial Blood Market to Reach USD 8.64 Billion by 2033 at 8.7% CAGR, Driven by Rising Demand for Blood Substitutes and Emergency Care Solutions</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416726515_k.jpg" alt="Artificial Blood Market to Reach USD 8.64 Billion by 2033 at 8.7% CAGR, Driven by Rising Demand for Blood Substitutes and Emergency Care Solutions" align="left" hspace="5" /><br/>The global artificial blood market reached USD 4,444.3 million in 2025 and is expected to reach USD 8,648.0 million by 2033, growing at a CAGR of 8.7% from 2026 to 2033. The market is witnessing steady growth driven by the<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474991/artificial-blood-market-to-reach-usd-8-64-billion-by-2033-at-8-7</link>
 <author>DataM intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474991/artificial-blood-market-to-reach-usd-8-64-billion-by-2033-at-8-7</guid>
 <pubDate>Thu, 16 Apr 2026 15:17:14 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416726515_k.jpg" length="2541" type="image/jpeg" />
</item>
<item>
 <title>Polymerase Chain Reaction Market Driving Growth in Molecular Diagnostics Through Rising Demand for Precision Medicine and Rapid Disease Detection</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416308818_k.jpg" alt="Polymerase Chain Reaction Market Driving Growth in Molecular Diagnostics Through Rising Demand for Precision Medicine and Rapid Disease Detection" align="left" hspace="5" /><br/>Market Size and Growth 2026

The Global Polymerase Chain Reaction Market Size Reached US$ 11.58 Billion in 2023 with a rise of US$ 12.33 Billion in 2024 and is expected to reach US$ 22.66 Billion by 2033, growing at a CAGR<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474987/polymerase-chain-reaction-market-driving-growth-in-molecular</link>
 <author>DataM  intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474987/polymerase-chain-reaction-market-driving-growth-in-molecular</guid>
 <pubDate>Thu, 16 Apr 2026 15:16:03 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416308818_k.jpg" length="1843" type="image/jpeg" />
</item>
<item>
 <title>Drug Eluting Stents Market to Reach USD 16.54 Billion by 2033, Growing at 8.70% CAGR from 2025-2033</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416715527_k.jpg" alt="Drug Eluting Stents Market to Reach USD 16.54 Billion by 2033, Growing at 8.70% CAGR from 2025-2033" align="left" hspace="5" /><br/>Market Summary
As per Data Bridge Market Research analysis, the drug eluting stents (DES) market was estimated at USD 8.49 billion in 2025. The market is expected to grow from USD 9.23 billion in 2026 to USD 16.54 billion in 2033,<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474981/drug-eluting-stents-market-to-reach-usd-16-54-billion-by-2033</link>
 <author>Data  Bridge Market Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474981/drug-eluting-stents-market-to-reach-usd-16-54-billion-by-2033</guid>
 <pubDate>Thu, 16 Apr 2026 15:14:14 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416715527_k.jpg" length="1447" type="image/jpeg" />
</item>
<item>
 <title>Automotive Digital Cockpit Market Size, Trends &amp; Growth 2026-2032 | Industry Outlook</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416564638_k.jpg" alt="Automotive Digital Cockpit Market Size, Trends & Growth 2026-2032 | Industry Outlook" align="left" hspace="5" /><br/>Automotive Digital Cockpit Market Introduction -

According to a newly published report by QY Research, the global Automotive Digital Cockpit Market 2026 delivers a comprehensive and data-driven analysis designed to enhance business decision-making and unlock high-growth opportunities across industries.

This study provides<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474973/automotive-digital-cockpit-market-size-trends-growth</link>
 <author>QYResearch.Inc</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474973/automotive-digital-cockpit-market-size-trends-growth</guid>
 <pubDate>Thu, 16 Apr 2026 15:11:17 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416564638_k.jpg" length="1366" type="image/jpeg" />
</item>
<item>
 <title>Fluoro-Enzymatic Assays Market to Reach USD 2.96 Billion by 2033 at 9.5% CAGR, Driven by Rising Demand for High-Sensitivity Diagnostic Technologies</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416283534_k.jpg" alt="Fluoro-Enzymatic Assays Market to Reach USD 2.96 Billion by 2033 at 9.5% CAGR, Driven by Rising Demand for High-Sensitivity Diagnostic Technologies" align="left" hspace="5" /><br/>The global fluoro-enzymatic assays market reached USD 1.18 billion in 2025 and is expected to reach USD 2.96 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market is witnessing strong growth driven by the<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474928/fluoro-enzymatic-assays-market-to-reach-usd-2-96-billion-by-2033</link>
 <author>DataM intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474928/fluoro-enzymatic-assays-market-to-reach-usd-2-96-billion-by-2033</guid>
 <pubDate>Thu, 16 Apr 2026 14:53:02 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416283534_k.jpg" length="2266" type="image/jpeg" />
</item>
<item>
 <title>Joint Pain Injection Market Driven by Expanding Use of Viscosupplementation in Osteoarthritis Treatment</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416397548_k.jpg" alt="Joint Pain Injection Market Driven by Expanding Use of Viscosupplementation in Osteoarthritis Treatment" align="left" hspace="5" /><br/>DataM Intelligence has released a new research report titled "Joint Pain Injection Market Size 2025" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players.<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474909/joint-pain-injection-market-driven-by-expanding-use</link>
 <author>DataM Intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474909/joint-pain-injection-market-driven-by-expanding-use</guid>
 <pubDate>Thu, 16 Apr 2026 14:48:44 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416397548_k.jpg" length="1612" type="image/jpeg" />
</item>
<item>
 <title>Electronic Clinical Outcome Assessment Solutions Market size to Reach USD 5.15 Billion by 2031, Driven by Patient-Centric Trials</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416487306_k.jpg" alt="Electronic Clinical Outcome Assessment Solutions Market size to Reach USD 5.15 Billion by 2031, Driven by Patient-Centric Trials" align="left" hspace="5" /><br/>Mordor Intelligence has published a new report on the electronic clinical outcome assessment solutions market, offering a comprehensive analysis of trends, growth drivers, and future projections. 

Electronic Clinical Outcome Assessment Solutions Market Overview 

According to Mordor Intelligence, the electronic clinical<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474895/electronic-clinical-outcome-assessment-solutions-market-size</link>
 <author>Mordor Intelligence Private Limited</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474895/electronic-clinical-outcome-assessment-solutions-market-size</guid>
 <pubDate>Thu, 16 Apr 2026 14:46:10 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416487306_k.jpg" length="1649" type="image/jpeg" />
</item>
<item>
 <title>Hot and Cold Therapy Packs Market size to Reach USD 2.21 Billion by 2031, Driven by Rising Demand for Non-Drug Pain Relief</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416217189_k.jpg" alt="Hot and Cold Therapy Packs Market size to Reach USD 2.21 Billion by 2031, Driven by Rising Demand for Non-Drug Pain Relief" align="left" hspace="5" /><br/>Mordor Intelligence has published a new report on the hot and cold therapy packs market, offering a comprehensive analysis of trends, growth drivers, and future projections. 

Hot and Cold Therapy Packs Market Overview  

According to Mordor Intelligence, the market<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474869/hot-and-cold-therapy-packs-market-size-to-reach-usd-2-21-billion</link>
 <author>Mordor Intelligence Private Limited</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474869/hot-and-cold-therapy-packs-market-size-to-reach-usd-2-21-billion</guid>
 <pubDate>Thu, 16 Apr 2026 14:40:19 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416217189_k.jpg" length="1606" type="image/jpeg" />
</item>
<item>
 <title>Scientology Church members Marked World Health Day in Europe and Beyond</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/416333032_k.jpg" alt="Scientology Church members Marked World Health Day in Europe and Beyond" align="left" hspace="5" /><br/>Scientology Marks World Health Day Through Drug Prevention, Blood Donation and Community Health Initiatives

Brussels, Brussels, Belgium, 16th Apr 2026 -- Churches of Scientology in several countries marked World Health Day 2026 through a range of activities intended to support both<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474868/scientology-church-members-marked-world-health-day-in-europe</link>
 <author>King Newswire</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474868/scientology-church-members-marked-world-health-day-in-europe</guid>
 <pubDate>Thu, 16 Apr 2026 14:40:04 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/416333032_k.jpg" length="2140" type="image/jpeg" />
</item>
<item>
 <title>Veterinary Diagnostic Imaging Market size to Reach USD 2.79 Billion by 2031 Driven by Rising Demand for Advanced Animal Care</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416104484_k.jpg" alt="Veterinary Diagnostic Imaging Market size to Reach USD 2.79 Billion by 2031 Driven by Rising Demand for Advanced Animal Care" align="left" hspace="5" /><br/>Mordor Intelligence has published a new report on the veterinary diagnostic imaging market, offering a comprehensive analysis of trends, growth drivers, and future projections. 

Introduction 

According to Mordor Intelligence, the veterinary diagnostic imaging market size was valued at USD 1.84<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474856/veterinary-diagnostic-imaging-market-size-to-reach-usd-2-79</link>
 <author>Mordor Intelligence Private Limited</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474856/veterinary-diagnostic-imaging-market-size-to-reach-usd-2-79</guid>
 <pubDate>Thu, 16 Apr 2026 14:34:45 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416104484_k.jpg" length="1532" type="image/jpeg" />
</item>
<item>
 <title>Disabled Assistive Devices Market to Reach USD 42.14 Billion by 2032, Growing at a CAGR of 5.90%</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416776889_k.jpg" alt="Disabled Assistive Devices Market to Reach USD 42.14 Billion by 2032, Growing at a CAGR of 5.90%" align="left" hspace="5" /><br/>Market Summary
As per Data Bridge Market Research analysis, the Disabled Assistive Devices Market was estimated at USD 28.21 billion in 2025. The market is expected to grow from USD 29.88 billion in 2026 to USD 42.14 billion in 2032, at<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474854/disabled-assistive-devices-market-to-reach-usd-42-14-billion</link>
 <author>Data Bridge Market Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474854/disabled-assistive-devices-market-to-reach-usd-42-14-billion</guid>
 <pubDate>Thu, 16 Apr 2026 14:33:50 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416776889_k.jpg" length="1424" type="image/jpeg" />
</item>
<item>
 <title>Protein Engineering Market to Reach USD 8.64 Billion by 2033 at 15.6% CAGR, Driven by Rising Demand for Biopharmaceuticals and Precision Medicine</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416989531_k.jpg" alt="Protein Engineering Market to Reach USD 8.64 Billion by 2033 at 15.6% CAGR, Driven by Rising Demand for Biopharmaceuticals and Precision Medicine" align="left" hspace="5" /><br/>The global protein engineering market reached USD 3,300.8 million in 2025 and is expected to reach USD 8,646.10 million by 2033, growing at a CAGR of 15.6% from 2026 to 2033. The market is witnessing strong growth driven by the<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474838/protein-engineering-market-to-reach-usd-8-64-billion-by-2033</link>
 <author>DataM intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474838/protein-engineering-market-to-reach-usd-8-64-billion-by-2033</guid>
 <pubDate>Thu, 16 Apr 2026 14:29:30 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416989531_k.jpg" length="2517" type="image/jpeg" />
</item>
<item>
 <title>Flow Cytometry Market Enters High-Growth Phase, Set to Double by 2032</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416596191_k.jpg" alt="Flow Cytometry Market Enters High-Growth Phase, Set to Double by 2032" align="left" hspace="5" /><br/>As per Data Bridge Market Research analysis, The Flow Cytometry Market was estimated at USD 7.10 billion in 2025. The market is expected to grow from USD 7.87 billion in 2026 to USD 14.71 billion in 2032, at a CAGR<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474823/flow-cytometry-market-enters-high-growth-phase-set-to-double</link>
 <author>Data Bridge Market Research</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474823/flow-cytometry-market-enters-high-growth-phase-set-to-double</guid>
 <pubDate>Thu, 16 Apr 2026 14:23:48 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416596191_k.jpg" length="1384" type="image/jpeg" />
</item>
<item>
 <title>VV ECLS Devices Market Set for Steady Growth at 9.4% CAGR Through 2033, Led by North America's 40% Market Share</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416644345_k.jpg" alt="VV ECLS Devices Market Set for Steady Growth at 9.4% CAGR Through 2033, Led by North America's 40% Market Share" align="left" hspace="5" /><br/>DataM Intelligence has released a new research report titled "Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474822/vv-ecls-devices-market-set-for-steady-growth-at-9-4-cagr-through</link>
 <author>DataM intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474822/vv-ecls-devices-market-set-for-steady-growth-at-9-4-cagr-through</guid>
 <pubDate>Thu, 16 Apr 2026 14:23:41 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416644345_k.jpg" length="1870" type="image/jpeg" />
</item>
<item>
 <title>New Pet-Friendly Sober Living Homes Open in Los Angeles, With Option to Bring a Pet to Sober Living</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/4/1/416449865_k.jpg" alt="New Pet-Friendly Sober Living Homes Open in Los Angeles, With Option to Bring a Pet to Sober Living" align="left" hspace="5" /><br/>Los Angeles, CA, United States, 16th Apr 2026 -- Paws in Recovery has officially launched pawsinrecovery.com, introducing a first-of-its-kind network of pet-friendly sober living homes in Los Angeles for both men and women. With locations in Mid-City and on the<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474815/new-pet-friendly-sober-living-homes-open-in-los-angeles-with</link>
 <author>King Newswire</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474815/new-pet-friendly-sober-living-homes-open-in-los-angeles-with</guid>
 <pubDate>Thu, 16 Apr 2026 14:20:05 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/4/1/416449865_k.jpg" length="2316" type="image/jpeg" />
</item>
<item>
 <title>Life Science Instruments and Consumables Market Growth Explained: Why 6.7% CAGR Through 2033 and What's Driving Growth?</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416137600_k.jpg" alt="Life Science Instruments and Consumables Market Growth Explained: Why 6.7% CAGR Through 2033 and What's Driving Growth?" align="left" hspace="5" /><br/>Market Size and Growth 2026

The Global Life Science Instruments And Consumables Market Size Reached US$ 94.78 Billion in 2024 from US$ 89.37 Billion in 2023 and is expected to reach US$ 167.98 Billion by 2033, growing at a CAGR of<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474811/life-science-instruments-and-consumables-market-growth</link>
 <author>DataM  intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474811/life-science-instruments-and-consumables-market-growth</guid>
 <pubDate>Thu, 16 Apr 2026 14:19:35 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416137600_k.jpg" length="2100" type="image/jpeg" />
</item>
<item>
 <title>Next-Generation Antibody Therapeutics Market to Reach USD 22.88 Billion by 2033 at 10.9% CAGR, Driven by Rising Demand for Precision Oncology and Targeted Biologics</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416727589_k.jpg" alt="Next-Generation Antibody Therapeutics Market to Reach USD 22.88 Billion by 2033 at 10.9% CAGR, Driven by Rising Demand for Precision Oncology and Targeted Biologics" align="left" hspace="5" /><br/>The global next-generation antibody therapeutics market reached USD 9.09 billion in 2024 and is expected to reach USD 22.88 billion by 2033, growing at a CAGR of 10.9% from 2025 to 2033. The market is witnessing strong growth driven by<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474809/next-generation-antibody-therapeutics-market-to-reach-usd</link>
 <author>DataM intelligence 4 Market Research LLP</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474809/next-generation-antibody-therapeutics-market-to-reach-usd</guid>
 <pubDate>Thu, 16 Apr 2026 14:18:47 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416727589_k.jpg" length="1994" type="image/jpeg" />
</item>
<item>
 <title>Healthtech Market Is Booming So Rapidly |Siemens Healthineers, GE HealthCare Technologies, Philips Healthcare, Medtronic</title>
 <description><![CDATA[<div><img border="0" src="https://cdn.open-pr.com/L/4/L416784164_k.jpg" alt="Healthtech Market Is Booming So Rapidly |Siemens Healthineers, GE HealthCare Technologies, Philips Healthcare, Medtronic" align="left" hspace="5" /><br/>The Global Healthtech Market is estimated to be valued at USD 1.25 Tn in 2026 and is expected to reach USD 3.07 Tn by 2033, exhibiting a compound annual growth rate (CAGR) of 13.7% from 2026 to 2033. 

The latest<br clear="all" /></div>]]></description>
 <link>https://www.openpr.com/news/4474796/healthtech-market-is-booming-so-rapidly-siemens-healthineers</link>
 <author>Coherent Market Insights</author>
 <category><![CDATA[Health & Medicine]]></category>
 <guid isPermaLink="true">https://www.openpr.com/news/4474796/healthtech-market-is-booming-so-rapidly-siemens-healthineers</guid>
 <pubDate>Thu, 16 Apr 2026 14:13:15 +0200</pubDate>
<enclosure url="https://cdn.open-pr.com/L/4/L416784164_k.jpg" length="2690" type="image/jpeg" />
</item>
 </channel>
</rss>
